메뉴 건너뛰기




Volumn 72, Issue 1-3, 2001, Pages 133-144

Drug permeation enhancement via buccal route: Possibilities and limitations

Author keywords

Bile salts; Buccal; Chitosan; Hydrocortisone; Morphine; Penetration enhancement; TGF

Indexed keywords

ACETIC ACID; ALPHA INTERFERON; ANTIINFLAMMATORY AGENT; BILE SALT; BUSERELIN; CHELATING AGENT; CHITOSAN; CYCLODEXTRIN; FATTY ACID; FATTY ACID DERIVATIVE; FLUORESCEIN ISOTHIOCYANATE; GLUCAGON LIKE PEPTIDE 1; GONADORELIN; HYDROCORTISONE; INSULIN; LAUROCAPRAM; MORPHINE; MORPHINE SULFATE; OCTREOTIDE; PENETRATION ENHANCING AGENT; PEPTIDE; SURFACTANT; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035858298     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(01)00269-3     Document Type: Article
Times cited : (255)

References (42)
  • 7
    • 0004901830 scopus 로고    scopus 로고
    • Buccal epithelial cell cultures as a model to study oral mucosal drug transport and metabolism
    • M.J. Rathbone (Ed.), Marcel Dekker, New York
    • (1996) Oral Mucosal Drug Delivery , pp. 101-119
    • Audus, K.L.1
  • 12
    • 0028011008 scopus 로고
    • An in vivo dog model for studying recovery kinetics of the buccal mucosa permeation barrier after exposure to permeation enhancers: Apparent evidence of effective evidence enhancement without tissue damage
    • (1994) Int. J. Pharm. , vol.101 , pp. 15-22
    • Zhang, J.1    Niu, S.2    Ebert, C.3    Stanley, T.H.4
  • 26
    • 0025113804 scopus 로고
    • Protease inhibitors and penetration enhancers as approaches to modify peptide absorption
    • (1990) J. Control. Release , vol.13 , pp. 213-223
    • Lee, V.H.L.1
  • 27


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.